Source: Eur Respir J, 58 (1) 2100041; 10.1183/13993003.00041-2021
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Robin Vos, Anke Van Herck. Pseudomonas aeruginosa and chronic lung allograft dysfunction: does evading an iceberg prevent the ship from sinking?. Eur Respir J, 58 (1) 2100041; 10.1183/13993003.00041-2021

Member's Comments

No comment yet.

Related content which might interest you: Pseudomonas aeruginosa eradication after lung transplantation: is it the tip of the iceberg? Source: Eur Respir J, 58 (1) 2004380; 10.1183/13993003.04380-2020 Year: 2021 Chronic but not intermittent infection with Pseudomonas aeruginosa is associated with global changes of the lung microbiome in cystic fibrosis Source: Eur Respir J, 50 (4) 1701086; 10.1183/13993003.01086-2017 Year: 2017 Pseudomonas and risk factor mitigation for chronic lung allograft dysfunction Source: Eur Respir J, 56 (4) 2001968; 10.1183/13993003.01968-2020 Year: 2020 Training dogs to differentiate Pseudomonas aeruginosa from other cystic fibrosis bacterial pathogens: not to be sniffed at? Source: Eur Respir J, 54 (5) 1900970; 10.1183/13993003.00970-2019 Year: 2019 Chronic lobe collapse: another bronchiectasis phenotype or a marker of Pseudomonas colonisation? Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017 Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre Source: Eur Respir J 2006; 27: 937-943 Year: 2006 Impact of Pseudomonas aeruginosa on exacerbation and death in patients with chronic obstructive pulmonary disease. Source: International Congress 2019 – Airway infection in COPD Year: 2019 Omics-based tracking of Pseudomonas aeruginosa persistence in “eradicated” cystic fibrosis patients Source: Eur Respir J, 57 (4) 2000512; 10.1183/13993003.00512-2020 Year: 2021 Bacterial cyanogenesis occurs in the cystic fibrosis lung Source: Eur Respir J 2008; 32: 329-333 Year: 2008 Pseudomonas before and after lung transplantation: to treat or not to treat? Source: Annual Congress 2012 - Respiratory infectious diseases Grand Round: an interactive session Year: 2012 Modelling acute lung injury: infections versus bacterial components Source: Annual Congress 2012 - PG4 Experimental models for respiratory medicine: strengths and limitations Year: 2012 Does Pseudomonas aeruginosa infection alter sputum viscoelastic properties in bronchiectasis patients? Source: International Congress 2018 – Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques Year: 2018 A comprehensive analysis of the impact of pseudomonas aeruginosa colonisation in adult bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Does a single Pseudomonas aeruginosa isolation predict COPD mortality? Source: Eur Respir J 2014; 44: 794-797 Year: 2014 How to manage pseudomonas infections: chronic and acute Source: CME Online 2019 Year: 2019 Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD. Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020 Does sputum induction improve Pseudomonas aeruginosa detection in cystic fibrosis? Source: Eur Respir J 2003; 22: Suppl. 45, 231s Year: 2003 LATE-BREAKING ABSTRACT: Pseudomonas aeruginosa strain prevalence, adaptation and diversification, during chronic lung infections of UK non-cystic fibrosis bronchiectasis patients Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis Source: Eur Respir J 2006; 28: 974-979 Year: 2006